跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
Philippines FDA
/
Briandazole
Approved
STANDARD
Briandazole
Reyoung Pharmaceutical Co., Ltd
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
e05d250105deebc4
Company
Reyoung Pharmaceutical Co., Ltd
Type
Standard
Approval Details
Approval Id
e05d250105deebc4
Drug Approval Philippines Name
Briandazole
Product Name
Briandazole
Registration Number
DRP-12424-04
Brand Name
Briandazole
Generic Name
Omeprazole (as sodium monohydrate)
Dosage Form
Lyophilized Powder for Injection (I.V.)
Dosage Strength
40 mg
Manufacturer
Reyoung Pharmaceutical Co., Ltd
Importer
GPC Geo Pharma Corporation
Distributor
PBD Pharmaceutical Product Distribution
Issuance Date
28 March 2024
Expiry Date
04 August 2027
Pharmacologic Category
Proton Pump Inhibitor
Classification
Prescription Drug (Rx)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
e05d250105deebc4
Type
Standard
Back to Philippines FDA Approvals